Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Non-Current Assets (2019 - 2025)

Silo Pharma's Non-Current Assets history spans 7 years, with the latest figure at $220312.0 for Q3 2025.

  • For Q3 2025, Non-Current Assets fell 27.75% year-over-year to $220312.0; the TTM value through Sep 2025 reached $220312.0, down 27.75%, while the annual FY2024 figure was $300360.0, 362.21% up from the prior year.
  • Non-Current Assets for Q3 2025 was $220312.0 at Silo Pharma, down from $279476.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $309464.0 in Q2 2024 and bottomed at $19375.0 in Q1 2021.
  • The 5-year median for Non-Current Assets is $88118.0 (2021), against an average of $140542.7.
  • The largest annual shift saw Non-Current Assets surged 403.71% in 2022 before it tumbled 51.53% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $87869.0 in 2021, then dropped by 19.4% to $70821.0 in 2022, then fell by 8.24% to $64983.0 in 2023, then soared by 362.21% to $300360.0 in 2024, then fell by 26.65% to $220312.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Non-Current Assets are $220312.0 (Q3 2025), $279476.0 (Q2 2025), and $295808.0 (Q1 2025).